prognosticul cancerului de col uterin în contextul unor - Gr.T. Popa

47. National Cancer Institute. What You Need To Know About
Cervical Cancer. www.cancer.gov.
48. Nicula F, Coza D, Suteu O, et al. The integrated role of the
Oncological Institute Prof Dr I Chiricuţă from Cluj Napoca:
Comprehensive centre for diagnosis and treatment of cancer in
prevention and cancer control in territories methodological
coordinated. National Congress of Oncology, Bucureşti, 23-25 Jun,
2005; Abstract in Rev Rom Oncol, 2005; 42-61.
49. OMS. Ghidul de diagnostic şi tratament al cancerului de col
uterin. 2009; 1059.
50. Pecorelli S, Zigliani I, Oldicino F. Revised FIGO stagind for
carcinom on the cervix. Int J Gynecol Obstet, 2009; 105: 8-108.
51. Petterson F. FIGO annual report on the results of treatment in
gynecological cancer. Int J Gynecol Obstet, 1991; 36: 27-130.
52. Pricop M. Oncologie ginecologică clinică. Ed Polirom, Iaşi,
2000; 229-230.
53. Richart RM, Wright TC Jr. Controversies in the management of
low-grade cervical intraepithelial neoplasia. Cancer, 1993; 71(Suppl
4): 1413-1421.
54. Shiohara S, Shiozawa T, Miyamoto T, et al. Expression of
cyclins, p53, and Ki-67 in cervical squamous cell carcinomas:
overexpression of cyclin A is a poor prognostic factor in stage Ib and
II disease. Virchows Arch, 2005; 446(6): 626-633.
55. Silberfab PM. Psychiatric problems in cervical cancer. Cancer,
1984; 53(Suppl 3): 820-824.
56. Sîrbu P, Chiricuţă I, Pandele A, et al. Chirurgia ginecologică. Ed
Medicală, vol 2, 1981; 701-922.
57. Spiegel D, Bloom JR. Pain in metastatic breast cancer. Cancer,
1983; 52: 341-345.
58. Spiegel D, Kraemer H, Bloom JR, et al. Effect of psychosocial
treatment on survival of patients with metastatic breast cancer.
Lancet, 1989; 2(8668): 888-891.
59. Surcel IV, Surcel M. Obstetrică şi ginecologie. Ed Dacia, Cluj-
Napoca, 2005; 910-913.
60. Şuteu O, Ghilezan N, Todor N, et al. Epidemiologia cancerului
de col uterin în România 1959-1999. Radioter Oncol Med, 2001; 1:
40-51; 233-245.
57